O-RAN ALLIANCE Broadens Its Industry Collaboration With ETSI, Announces Its 3rd Whitepaper, and 4th Release of Open Software
16.8.2021 15:58:00 EEST | Business Wire | Press release
The O-RAN ALLIANCE welcomes 1&1 as its newest operator member, extending the world-wide community of 30 mobile network operators committed to deployment of open and intelligent Radio Access Networks (RAN).
The Third O-RAN Whitepaper Focuses on O-RAN Minimum Viable Plan and Acceleration towards Commercialization
Published on June 29, 2021, the whitepaper describes key areas to accelerate and enable the introduction of the rich capabilities of O-RAN Architecture in commercial networks. It also outlines a minimum viable set of end-to-end specifications for selected use cases to deploy a secure, multi-vendor interoperable network. The full whitepaper is available at our website.
O-RAN ALLIANCE Sets Cooperation with ETSI and TSDSI
To ensure compatibility and to avoid duplication of work, the O-RAN ALLIANCE’s specification effort builds on common standards and values alignment with other industry bodies.
On May 27, 2021, the O-RAN ALLIANCE signed a cooperation agreement with the European Telecommunications Standards Institute (ETSI). O-RAN ALLIANCE shares with ETSI a common objective to perform and promote regional and international standardization for 3GPP based technologies.
The O-RAN ALLIANCE also signed a Memorandum of Understanding with the Telecommunications Standards Development Society, India (TSDSI). It expresses mutual interest in cooperation to grow open interfaces and the open RAN ecosystem in the India subcontinent region.
New Open Test and Integration Centers (OTIC)
On June 28, 2021, the O-RAN ALLIANCE approved three new OTICs:
- European OTIC in Madrid hosted by Telefonica
- European OTIC in Paris hosted by Orange
- Auray OTIC and Security Lab (Taiwan) hosted by Auray Technology
The newly approved OTICs are widening the collaborative, open, and impartial working environment to ensure consistency and quality of testing of O-RAN products and solutions. See the full list of approved OTICs at our website.
New Standards Collaboration Copyright License (SCCL) to Simplify the Open Source Development
O-RAN ALLIANCE has introduced a new Standards Collaboration Copyright License (SCCL). The SCCL has been developed to simplify the process of producing open source SW based on standards, by defining a license that will make it easier for the open source community to use code-like sections of O-RAN specifications in their implementations.
“We believe that open source will play an important role in enabling open implementations, even if an operator never deploys stand-alone open source code in its network,” said Alex Jinsung Choi, Chief Operating Officer of the O-RAN ALLIANCE and SVP of Strategy and Technology Innovation, Deutsche Telekom. “The open source can help suppliers build their commercial implementations, and perhaps most importantly, it can also make it easier to achieve cross-vendor integration and interoperability between open RAN components by providing a reference implementation.”
The June 2021 O-RAN ALLIANCE Industry Summit Available for Replay
The O-RAN ALLIANCE Industry Summit on June 29 provided valuable insights on the latest O-RAN development, especially in terms of commercialization, security and performance. The 90-minute event is available for replay on demand at our website.
4th Release of Open Software for the RAN Developed by the O-RAN Software Community
The O-RAN Software Community (OSC or O-RAN SC) was formed in partnership with the Linux Foundation in April 2019, to support software development of open RAN solutions available to everyone.
The “D” release delivers major enhancements including support for closed-loop processing use cases, continued evolution of Non-Real-Time RAN Intelligent Control (Non-RT RIC) platform, new and enhanced xApps for the Near-Real-Time Radio Intelligent Controller (Near-RT RIC), as well as new performance monitoring and alarm support.
To deep-dive into the D release and to get the open software, please visit the O-RAN Software Community website.
"With the joint efforts from the mobile carriers, traditional vendors, and more technology partners onboard, the 4th release is the first try to get the full O-RAN software stack working, and in addition we can now declare it is a smart RAN," said Chih-Lin I, the Co-chair of O-RAN Technical Steering Committee. "We are glad to see major accomplishments in the D release, and that our lab now delivers a reliable environment for the software community to continue new feature implementation and integration test verification."
"Ericsson continues to be very active in O-RAN ALLIANCE making contributions to specifications and O-RAN architecture evolution,” said Per Beming, Head of Standard and Industry Initiatives at Ericsson. "In the OSC D release, Ericsson has continued as the key contributor to the Non-RT RIC project by further evolving support for the A1 interface, in addition to laying the foundations for Non-RT RIC automation applications and the R1 interface. Delivering a framework which supports rApp development is a key aspect of intent based management with the A1 interface, enabling more fine-grained intelligent control and optimization decisions.”
“We are excited to extend our contributions to another Linux Foundation project. Our most recent contributions towards the OAM component in the D-release of O-RAN SC demonstrate PANTHEON.tech's commitment to help our customers with the evolution and adoption of open-source projects," said Miroslav Miklus, Chief Product Officer at PANTHEON.tech.
”Making the RAN intelligent and context-aware is critically important for network optimization and automation. The focus of Samsung's O-RAN SC contribution has been towards enhancing the A1-Enrichment Information (A1-EI) & xAPP Framework. Overall, we believe that strengthening the O-RAN AI/ML Framework will play a big role in making operators achieve proactive closed-loop optimization and automation of RAN operations," said Dr. Sunghyun Choi, Corporate SVP and Head of Advanced Communications Research Center of Samsung Research, Samsung Electronics.
“Xoriant has participated in the O-RAN Software Community by contributing code to O1/VES interface of SMO,” said Girish Gaitonde, CEO of Xoriant. “We contributed to the initial implementation of the O-RAN O1/VES interface for OSC, with the idea to enable a close loop automation use-case between SMO and the other network functions such as O-DU, O-RU, O-CU and the Near RT-RIC.”
About O-RAN ALLIANCE
The O-RAN ALLIANCE is a world-wide community of 315 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, the O-RAN ALLIANCE’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN based mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, the O-RAN ALLIANCE publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.
For more information please visit www.o-ran.org.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210816005392/en/
Contact information
O-RAN ALLIANCE PR Contact
Zbynek Dalecky
pr@o-ran.org
O-RAN ALLIANCE e.V.
Buschkauler Weg 27
53347 Alfter/Germany
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
